GSK share price set for ex-dividend week after Friday rise — what investors watch next
GSK shares closed Friday up 1.1% at 2,161 pence, ahead of a Feb. 19 ex-dividend date for its 18 pence Q4 payout. The company reaffirmed a £2 billion buyback through mid-2026 and expects 70 pence per share in 2026 dividends. The European Commission approved Nucala for certain COPD patients. China accepted GSK’s regulatory filing for its RSV vaccine Arexvy.